The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator
- PMID: 12067302
- PMCID: PMC1906249
- DOI: 10.1046/j.1365-2249.2002.01872.x
The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator
Abstract
The synthetic immunomodulator murabutide (MB) presents multiple biological activities with minimal toxicity in animals and in man. Although MB is known to target cells of the reticuloendothelial system and to regulate cytokine synthesis, the molecular mechanisms underlying several of its biological effects are still largely unknown. In an effort to define cellular factors implicated in the immunomodulatory and HIV-suppressive activities of MB, we have undertaken profiling the regulated expression of genes in human monocyte-derived macrophages (MDM) following a 6-h stimulation with this synthetic glycopeptide. Oligonucleotide microarray analysis was performed on RNA samples of differentiated MDM from four separate donors, using probe sets corresponding to 1081 genes. We have identified, in a reproducible fashion, the enhanced expression of 40 genes and the inhibition of 16 others in MB-treated MDM. These regulated genes belonged to different families of immune mediators or their receptors, transcription factors and kinases, matrix proteins and their inhibitors, ion channels and transporters, and proteins involved in cell metabolic pathways. Additional verification of the regulated expression of selected genes was carried out using Northern blots or the quantification of released proteins in MDM cultures. The profile of MB-regulated genes in MDM provides a molecular basis for some of its previously reported biological activities, and reveals new set of genes targeted by the immunomodulator suggesting potential application in novel therapeutic indications.
Figures


Similar articles
-
Differentially expressed genes in HIV-1-infected macrophages following treatment with the virus-suppressive immunomodulator murabutide.Virus Res. 2004 Jan;99(1):25-33. doi: 10.1016/j.virusres.2003.09.011. Virus Res. 2004. PMID: 14687943
-
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.Eur J Immunol. 2001 Jul;31(7):1962-71. doi: 10.1002/1521-4141(200107)31:7<1962::aid-immu1962>3.0.co;2-v. Eur J Immunol. 2001. PMID: 11449348
-
The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.J Virol. 2000 Sep;74(17):7794-802. doi: 10.1128/jvi.74.17.7794-7802.2000. J Virol. 2000. PMID: 10933686 Free PMC article.
-
Murabutide revisited: a review of its pleiotropic biological effects.Curr Med Chem. 2013;20(16):2068-79. doi: 10.2174/0929867311320160002. Curr Med Chem. 2013. PMID: 23531213 Review.
-
Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.J Antimicrob Chemother. 2003 Jan;51(1):5-8. doi: 10.1093/jac/dkg063. J Antimicrob Chemother. 2003. PMID: 12493780 Review. No abstract available.
Cited by
-
Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.J Control Release. 2018 Mar 10;273:147-159. doi: 10.1016/j.jconrel.2018.01.027. Epub 2018 Feb 2. J Control Release. 2018. PMID: 29407676 Free PMC article.
-
Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.Anal Cell Pathol (Amst). 2018 Feb 14;2018:8047610. doi: 10.1155/2018/8047610. eCollection 2018. Anal Cell Pathol (Amst). 2018. PMID: 29666781 Free PMC article. Review.
-
Translation of peptidoglycan metabolites into immunotherapeutics.Clin Transl Immunology. 2019 Nov 29;8(12):e1095. doi: 10.1002/cti2.1095. eCollection 2019. Clin Transl Immunology. 2019. PMID: 31798878 Free PMC article. Review.
-
[Microarray-based transcriptome analyses in infectious diseases. A new diagnostic method].Internist (Berl). 2006 Jun;47 Suppl 1:S6, S8-13. doi: 10.1007/s00108-006-1627-6. Internist (Berl). 2006. PMID: 16773368 Review. German.
-
Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.Curr Bioact Compd. 2011 Sep;7(3):180-197. doi: 10.2174/157340711796817913. Curr Bioact Compd. 2011. PMID: 22180736 Free PMC article.
References
-
- Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52. - PubMed
-
- Marton MJ, DeRisi JL, Bennett HA, et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med. 1998;4:1293–301. - PubMed
-
- Baron S, Tyring SK, Fleischmann WR, Jr, et al. The interferons. Mechanisms of action and clinical applications. JAMA. 1991;266:1375–83. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous